From: Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
PDXK Low (N = 17) | PDXK High (N = 13) | P-value | |
---|---|---|---|
Gender | |||
Female | 2 (11.8%) | 1 (7.7%) | 1 |
Male | 15 (88.2%) | 12 (92.3%) | |
Age (years) | |||
Mean (SD) | 47.9 (12.5) | 51.6 (7.78) | 0.333 |
Median [Min, Max] | 47.0 [30.0, 74.0] | 50.0 [40.0, 65.0] | |
AFP | |||
< 20 | 8 (47.1%) | 7 (53.8%) | 1 |
> 20 | 9 (52.9%) | 6 (46.2%) | |
HBsAg | |||
Mean (SD) | 0.765 (0.437) | 0.846 (0.376) | 0.588 |
Median [Min, Max] | 1.00 [0, 1.00] | 1.00 [0, 1.00] | |
Distant metastases | |||
Mean (SD) | 0.118 (0.332) | 0.231 (0.439) | 0.446 |
Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | |
Tumor size (cm) | |||
< 3 | 5 (29.4%) | 2 (15.4%) | 0.642 |
> 3 | 12 (70.6%) | 11 (84.6%) | |
Tumor count | |||
Mean (SD) | 1.12 (0.485) | 1.46 (0.967) | 0.257 |
Median [Min, Max] | 1.00 [1.00, 3.00] | 1.00 [1.00, 4.00] | |
PVTT | |||
Mean (SD) | 0.118 (0.332) | 0.308 (0.480) | 0.236 |
Median [Min, Max] | 0 [0, 1.00] | 0 [0, 1.00] | |
Cirrhosis | |||
Mean (SD) | 0.529 (0.514) | 0.385 (0.506) | 0.448 |
Median [Min, Max] | 1.00 [0, 1.00] | 0 [0, 1.00] | |
BCLC stage | |||
A | 13 (76.5%) | 8 (61.5%) | 0.665 |
B | 1 (5.9%) | 1 (7.7%) | |
C | 3 (17.6%) | 4 (30.8%) | |
TNM stage | |||
I Stage | 9 (52.9%) | 5 (38.5%) | 0.426 |
II Stage | 4 (23.5%) | 2 (15.4%) | |
III Stage | 4 (23.5%) | 6 (46.2%) | |
Tumor grade | |||
2 | 9 (52.9%) | 2 (15.4%) | 0.104 |
3 | 7 (41.2%) | 10 (76.9%) | |
4 | 1 (5.9%) | 1 (7.7%) |